Delivery Order SPE2DB24D2010-SPE2DB25FAAWN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,032.44 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a routine medical supply procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded a $1,376.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMOVAX Rabies Vaccine vials. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), requires completion by July 28, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a Delivery Order valued at $4,315.56 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials, with a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract reflects DLA's ongoing pharmaceutical procurement needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $12,591.13 under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,227.50 delivery order for IMOVAX Rabies Vaccine vials under a firm fixed-price contract type. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials. The contract has a ceiling value of $1,079.35 and a completion date of September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, vaccines, and medical supplies, to support military...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a ceiling value of $1,942.83 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,472,780 Imovax rabies vaccine vials. The $5,612.62 contract has a completion date of January 30, 2024. This delivery order is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.75 firm fixed-price delivery order is for IMOVAX Rabies Vaccine Vials and has a completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Imovax Rabies Vaccine vials on July 29, 2025, under a firm fixed-price contract valued at $3,341.25. This non-set-aside award represents a child delivery order sourced through the Defense Logistics Agency's Medical Supply Chain, reflecting the company's ongoing role as a critical pharmaceutical distributor for federal medical procurement. The ultimate completion date is scheduled for July...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAWNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,682.50 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine Vials, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, awarded on August 19, 2025, represents a non-competitive award under an existing contract vehicle. The vaccine will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply requirements, particularly for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies globally to support military healthcare programs and other federal health agencies including the Defense Health Agency and U.S. Coast Guard. The current award demonstrates the company's ongoing role as a critical distributor of essential medical commodities within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/19/25 |